Burgess Shawn C, He TianTeng, Yan Zheng, Lindner Jill, Sherry A Dean, Malloy Craig R, Browning Jeffrey D, Magnuson Mark A
The Advanced Imaging Research Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75235-9085, USA.
Cell Metab. 2007 Apr;5(4):313-20. doi: 10.1016/j.cmet.2007.03.004.
When dietary carbohydrate is unavailable, glucose required to support metabolism in vital tissues is generated via gluconeogenesis in the liver. Expression of phosphoenolpyruvate carboxykinase (PEPCK), commonly considered the control point for liver gluconeogenesis, is normally regulated by circulating hormones to match systemic glucose demand. However, this regulation fails in diabetes. Because other molecular and metabolic factors can also influence gluconeogenesis, the explicit role of PEPCK protein content in the control of gluconeogenesis was unclear. In this study, metabolic control of liver gluconeogenesis was quantified in groups of mice with varying PEPCK protein content. Surprisingly, livers with a 90% reduction in PEPCK content showed only a approximately 40% reduction in gluconeogenic flux, indicating a lower than expected capacity for PEPCK protein content to control gluconeogenesis. However, PEPCK flux correlated tightly with TCA cycle activity, suggesting that under some conditions in mice, PEPCK expression must coordinate with hepatic energy metabolism to control gluconeogenesis.
当饮食中缺乏碳水化合物时,肝脏通过糖异生作用生成维持重要组织新陈代谢所需的葡萄糖。磷酸烯醇式丙酮酸羧激酶(PEPCK)的表达通常被认为是肝脏糖异生作用的控制点,其表达通常受循环激素调节,以匹配全身葡萄糖需求。然而,在糖尿病中这种调节会失效。由于其他分子和代谢因素也会影响糖异生作用,PEPCK蛋白含量在糖异生控制中的具体作用尚不清楚。在本研究中,对PEPCK蛋白含量不同的小鼠组肝脏糖异生的代谢控制进行了量化。令人惊讶的是,PEPCK含量降低90%的肝脏糖异生通量仅降低了约40%,这表明PEPCK蛋白含量控制糖异生的能力低于预期。然而,PEPCK通量与三羧酸循环活性密切相关,这表明在小鼠的某些条件下,PEPCK表达必须与肝脏能量代谢协调以控制糖异生。